Fatigue News and Research

RSS

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

A new drug, anamorelin, improves appetite and body mass in patients with advanced lung cancer who are suffering cancer anorexia and cachexia, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

29 Sep 2014

Bioregional approach can help improve human and environmental health

In a paper published this week online in Global Society, researchers with University of California, San Diego School of Medicine and the Urban Studies and Planning Program, also at UC San Diego, present a bioregional guide that merges place-based (territorial) city planning and ecosystem management along the United States-Mexico border as way to improve human and environmental health.

27 Sep 2014

Australian researchers use hookworms to reduce symptoms of celiac disease

Australian researchers have achieved groundbreaking results in a clinical trial using hookworms to reduce the symptoms of celiac disease.

26 Sep 2014

Researchers examine how telephone-based coaching could help COPD patients

Coaching patients with chronic obstructive pulmonary disease to manage stress, practice relaxation and participate in light exercise can boost a patient's quality of life and can even improve physical symptoms, researchers at Duke Medicine report.

26 Sep 2014

New findings raise hope for novel class of drugs to treat lupus

New findings by a biomedical engineer and his team at the University of Houston raise hope for a new class of drugs to treat lupus that may not include the long list of adverse risks and side effects often associated with current treatments for this disease.

25 Sep 2014

Foot drop stimulator may facilitate recovery from common complication of stroke

Kessler Foundation scientists have published a study showing that use of a foot drop stimulator during a task-specific movement for 4 weeks can retrain the neuromuscular system. This finding indicates that applying the foot drop stimulator as rehabilitation intervention may facilitate recovery from this common complication of stroke.

24 Sep 2014

Epidurals and reduced postpartum depression: an interview with Dr. Zakowski

The “maternity blues”, which resolve within 10 days of giving birth, occurs in up to 80% of new moms. A major depressive episode, by Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria, is defined as having at least a 2-week period of persistent depressed mood ...

23 Sep 2014

Pilot study shows benefits of psychoeducational wellness program in MS people

Kessler researchers have published a pilot study showing the benefits of a 10-week psychoeducational wellness program in people with multiple sclerosis (MS). Improvements were seen in mood, overall mental health, perceived stress, and pain.

23 Sep 2014

Caltech researcher explores link between variable heart rate, health and fitness

Although the heart beats out a very familiar "lub-dub" pattern that speeds up or slows down as our activity increases or decreases, the pattern itself isn't as regular as you might think. In fact, the amount of time between heartbeats can vary even at a "constant" heart rate-and that variability, doctors have found, is a good thing.

23 Sep 2014

Absence of thyroid hormone during development can cause congenital deafness

Fatigue, weight gain, chills, hair loss, anxiety, excessive perspiration - these symptoms are a few of the signs that the thyroid gland, which regulates the body's heart rate and plays a crucial role in its metabolism, has gone haywire.

23 Sep 2014

Bose Corporation introduces DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices

Bose Corporation has introduced DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices. Featuring proprietary Bose® controls and linear motor technology, the DuraPulse system enables research and development engineers to run tests at frequencies higher than ever before -- exceeding 30 Hz without the loss of waveform fidelity. And with Bose PeakIQ™ control technology, the DuraPulse system also prevents high-pressure spikes during valve closing.

From TA Instruments 23 Sep 2014

Amgen seeks FDA approval for leukemia drug blinatumomab

Amgen today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration seeking approval for its investigational bispecific T cell engager (BiTE) antibody construct, blinatumomab.

22 Sep 2014

NPS MedicineWise launches new diagnostic approach for fatigue

Fatigue is a common complaint accounting for around 3-7% of all presentations to general practitioners. To help health professionals understand the limitations and appropriate use of diagnostic tests relating to fatigue NPS MedicineWise has launched a new program—Back to basics for fatigue: a diagnostic approach.

19 Sep 2014

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Lack of sleep can make you sick. And while everybody has the occasional restless night, for those who suffer from chronic insomnia — some 15 percent of older adults in the United States — that sleep loss can increase the risk for cardiovascular disease, hypertension, weight gain, type 2 diabetes, and even lead to an earlier death.

18 Sep 2014

Scientists develop first blood test to diagnose major adult depression

The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine- scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.

18 Sep 2014

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Immune Pharmaceuticals Inc. announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC).

18 Sep 2014

Ramucirumab effective second-line option for NSCLC

The monoclonal antibody ramucirumab, when added to second-line docetaxel, significantly improves the overall survival of patients with stage IV non-small-cell lung cancer, show the findings of the REVEL trial.

17 Sep 2014

Study links slowed processing speed with executive deficits in individuals with multiple sclerosis

Kessler Foundation researchers have published a study supporting the role of slowed processing speed in the executive deficits found in individuals with multiple sclerosis (MS).

17 Sep 2014

Warwick researchers discover novel drug target for treating postpartum haemorrhage

Researchers at the University of Warwick have discovered a new target for drugs that could prevent the deaths of thousands of women in the developing world due to heavy blood loss after childbirth.

17 Sep 2014

Thoracic radiotherapy reduces cancer recurrence in SCLC patients, shows new study

Treating advanced small-cell lung cancer (SCLC) with thoracic (or chest) radiation therapy in addition to standard treatment significantly prolongs long-term survival and reduces cancer recurrence in the chest by almost 50%, according to new research published in The Lancet and being presented simultaneously at ASTRO's 2014 Annual Meeting in San Francisco.

16 Sep 2014

Fatigue News and Research

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

Bioregional approach can help improve human and environmental health

Australian researchers use hookworms to reduce symptoms of celiac disease

Researchers examine how telephone-based coaching could help COPD patients

New findings raise hope for novel class of drugs to treat lupus

Foot drop stimulator may facilitate recovery from common complication of stroke

Epidurals and reduced postpartum depression: an interview with Dr. Zakowski

Pilot study shows benefits of psychoeducational wellness program in MS people

Caltech researcher explores link between variable heart rate, health and fitness

Absence of thyroid hormone during development can cause congenital deafness

Bose Corporation introduces DuraPulse™, a new instrument for accelerated durability testing of heart valve replacement devices

Amgen seeks FDA approval for leukemia drug blinatumomab

NPS MedicineWise launches new diagnostic approach for fatigue

Reducing insomnia can decrease inflammation, lower risk for chronic disease in older adults

Scientists develop first blood test to diagnose major adult depression

Immune begins bertilimumab Phase II clinical trial for treatment of ulcerative colitis

Ramucirumab effective second-line option for NSCLC

Study links slowed processing speed with executive deficits in individuals with multiple sclerosis

Warwick researchers discover novel drug target for treating postpartum haemorrhage

Thoracic radiotherapy reduces cancer recurrence in SCLC patients, shows new study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News